Tirzep Injection 5 mg/0.5 ml contains Tirzepatide, a dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist. It is indicated for adults with type 2 diabetes mellitus (T2DM) to improve glycemic control. By simultaneously targeting the GIP and GLP-1 pathways, Tirzepatide enhances insulin secretion, suppresses glucagon release, slows gastric emptying, and reduces appetite, helping to manage blood glucose levels and support weight reduction.

This higher-dose formulation (5 mg) is typically used after initial titration from lower doses to optimize glycemic control while minimizing gastrointestinal side effects.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Indications

Tirzep Injection is indicated for:

• Adults with type 2 diabetes mellitus requiring additional glycemic control
• Adjunct therapy for patients not adequately controlled with diet and exercise
• Combination therapy with oral antihyperglycemic agents when needed
• Patients seeking metabolic benefits including weight management

Mechanism of Action

Tirzepatide exerts its effects through dual receptor agonism:

• GIP receptor activation: Enhances glucose-dependent insulin secretion and improves postprandial glucose control.
• GLP-1 receptor activation: Suppresses glucagon release, slows gastric emptying, and reduces appetite.
• These combined actions lead to better overall glycemic control, reduced HbA1c, and potential weight reduction.

Dosage and Administration

• Administered as a subcutaneous injection once weekly.
• Typical dose progression: Start at 2.5 mg, then increase to 5 mg as directed by the physician.
• Inject into the abdomen, thigh, or upper arm; rotate injection sites to reduce local reactions.
• Do not mix with other insulin or injectable medications.
• Follow the prescribed schedule strictly to maintain consistent glycemic control.

Benefits

• Effective reduction in HbA1c levels for type 2 diabetes
• Supports weight reduction as part of diabetes management
• Once-weekly dosing enhances convenience and adherence
• Reduces fasting and postprandial blood glucose levels
• Dual GIP/GLP-1 action provides superior metabolic control compared to single-agent therapy

Side Effects

Common side effects:

• Nausea, vomiting, or diarrhea
• Injection site reactions (redness, itching, swelling)
• Decreased appetite
• Mild headache or fatigue

Serious but rare side effects:

• Hypoglycemia, especially when combined with insulin or sulfonylureas
• Pancreatitis (severe persistent abdominal pain)
• Allergic reactions or anaphylaxis
• Potential thyroid tumors (rare; contraindicated in patients with personal or family history of medullary thyroid carcinoma)

Seek immediate medical attention if severe symptoms or allergic reactions occur.

Precautions and Warnings

• Not for type 1 diabetes or diabetic ketoacidosis.
• Monitor for pancreatitis in patients with a history of gastrointestinal disorders.
• Pregnancy and breastfeeding should only use under specialist supervision.
• Regular blood glucose monitoring is essential, particularly when used with other antihyperglycemic medications.
• Use with caution in patients with severe renal or hepatic impairment.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Drug Interactions

Tirzep Injection may interact with:

• Other antidiabetic medications (risk of hypoglycemia)
• Oral medications with narrow therapeutic indices (due to delayed gastric emptying)
• Drugs affecting gastrointestinal motility

Always inform your healthcare provider about all medications, supplements, or herbal products being taken.

Storage

• Store in a refrigerator at 2–8°C; do not freeze
• Protect from light and heat
• Keep out of reach of children
• Do not use after the expiration date
• Once opened, follow package instructions for usage period.